Mutational Testing

/Tag:Mutational Testing

New Technology Developed Which Can Predict GIST Patient’s Response to Drugs with Amazing Accuracy

Researchers have developed a test that can accurately identify over 20% of GIST patients that are unlikely to respond to currently approved treatments. In addition, it can identify which patients need a higher dose [...]

By | 2018-07-09T09:57:06+00:00 June 29th, 2018|GIST Education, Mutational Testing, News, Newsletter|

Mutational Analysis of GISTs: How, When, and Why

Please join us for an afternoon of learning about the importance of and the science behind mutational testing with pathologist and GIST specialist, Dr. Christopher Corless of Portland's Oregon Health and Science University. This presentation [...]

By | 2015-08-28T13:35:58+00:00 August 12th, 2015|GIST Education, News, Webcast|

LRG patient registry: powerful tool for patients, physicians and researchers

The time it takes between the appearance of first symptoms of a rare disease and when the correct diagnosis is given, is often years if not decades instead of days or weeks like it is [...]

By | 2015-11-05T10:07:39+00:00 October 24th, 2014|News, Patient Registry, Research, Tissue Bank|

Personalized Medicine – Another Look

The issue of personalized medicine, also referred to as "precision medicine" in the article, was addressed in a newsletter article by LRG Executive Director Norman Scherzer in February. We hope to follow up with more articles on the topic soon.

By | 2014-09-14T11:30:48+00:00 April 22nd, 2013|Advocacy, Mutational Testing, News|

LRG & colleagues make their mark on 17th annual CTOS meeting in Prague

Representatives from the Life Raft Group recently traveled to Prague, Czech Republic to attend the annual Connective Tissue Oncology Society (CTOS) meeting. CTOS is an international group comprised of physicians and scientists with a primary interest in the tumors of connective tissues.

By | 2014-09-14T11:31:32+00:00 February 1st, 2013|Events, News|

Mutation Types

Learn about various mutation types. There are several types of gene mutations that can lead to Gastrointestinal Stromal Tumors. These include KIT mutations, PDGFRA mutations and BRAF and SDH mutations. As each of these involves [...]

By | 2014-09-14T11:32:30+00:00 September 20th, 2012|GIST Education|

State of the GIST Community Part 3: What do we know about mutational testing?

As of May 1, 2011, the LRG patient registry only received 377 reports of mutations out of 1,327 patients, which only represents 28 percent of the entire registry. Part of this may be related to the fact that mutational testing is not common practice at diagnosis.

By | 2014-09-17T10:15:15+00:00 June 1st, 2011|Mutational Testing, News|

Recent Posts

Upcoming Events

  1. Michigan GDOL 2018

    October 27 @ 8:00 AM - 3:00 PM